Evidence map›Paper›PMID 41480158›Full record

ArticleNew microbes and new infections2026

Improving antibiotic prescribing in LMICs: Insights from an outpatient clinic in Pakistan.

Tamim Khawaja, Mikael Kajova, Anu Kantele

Abstract read
In one paragraph

Article in New microbes and new infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tamim KhawajaDepartment of Infectious Diseases, Inflammation Centre, University of Helsinki and Helsinki University Hospital, P.O. Box 340, 00029 HUS, Finland.
Mikael KajovaDepartment of Infectious Diseases, Inflammation Centre, University of Helsinki and Helsinki University Hospital, P.O. Box 340, 00029 HUS, Finland.
Anu KanteleDepartment of Infectious Diseases, Inflammation Centre, University of Helsinki and Helsinki University Hospital, P.O. Box 340, 00029 HUS, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Most human antibiotic use occurs in outpatient care and is a key driver of antimicrobial resistance (AMR). Although sales statistics suggest that high-income countries consume more antibiotics overall, the steepest growth is seen in low- and middle-income countries. Sales data - incomplete and non-transparent - reveal little about prescriptions to individual patients. Detailed, clinic-level data are essential for identifying targets for stewardship.We investigated antibiotic use and prescription appropriateness in an outpatient clinic in Pakistan - a country with some of the world's highest reported AMR prevalences. Methods: Patients attending an outpatient clinic near Lahore were interviewed immediately after their clinic visit and again one month later. Clinical data were collected through patient interviews, and antibiotic prescriptions were extracted from patient records. Results: Of the 983 participants, 398 (40.5 %) were prescribed antibiotics at the primary visits. Metronidazole was the single most common agent, followed by first-generation cephalosporins, fluoroquinolones, and amoxicillin-clavulanate; phenoxymethylpenicillin and amoxicillin were only minimally prescribed. One-third of prescriptions (33.2 %) were combination regimens, 90.2 % of which included metronidazole. Guideline-concordant first- or second-line choices accounted for only 23.4 % of prescriptions.Of all patients, 493 (50.2 %) attended a one-month control visit. Of these, 233 (47.3 %) also saw a practitioner during the visit; 73 of them (31.3 %) were prescribed antibiotics. Conclusions: Antibiotic prescribing was excessive and discordant with recommended first-line therapies, favouring broad-spectrum agents and combination treatments - practices likely influenced by the negligible time available per patient. Our findings highlight the need to adapt antimicrobial stewardship interventions to limited-resource contexts.

Indexed as

Antibiotic stewardshipAntimicrobial resistance (AMR)Guideline adherenceLow- and middle-income countries (LMICs)Outpatient prescribingPakistanResource-limited settings

Identifiers

PMID41480158
PMCPMC12754384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.